Healthians vs Redcliffe Labs: revenue, valuation and funding compared
The short answer
Redcliffe Labs reported the highest revenue, ₹419 crore in FY25, against Healthians ₹357 crore in FY26. Healthians was profitable in the latest year reported; Redcliffe Labs reported a loss. Figures are for each company's latest reported year: FY26 for Healthians, FY25 for Redcliffe Labs.
Healthians and Redcliffe Labs are two diagnostics companies that compete for the same Indian patients, especially for tests booked online and collected at home. Healthians offers at-home diagnostic tests across 250+ cities. Redcliffe Labs is a diagnostics chain with labs, collection centres and home testing.
Healthians' latest row is FY26 and Redcliffe's is FY25, so FY25 is the year they share. Every number on this page comes from the two companies' StopDown profiles, where each figure carries its source.
Side by side
| Healthians | Redcliffe Labs | |
|---|---|---|
| Founded | — | 2018 |
| Based in | Gurugram | Noida |
| What it sells | At-home diagnostic tests across 250+ cities | Diagnostics chain with labs, collection centres and home testing |
| Status | Private | Private |
| Revenue, latest year | ₹357 crore FY26 | ₹419 crore FY25 |
| Revenue, year before | ₹263 crore FY25 | ₹348 crore FY24 |
| Growth | +36% (FY25 to FY26) | +20% (FY24 to FY25) |
| Net profit (loss), latest year | ₹5.4 crore FY26 | ₹250 crore loss FY24 |
| Last disclosed valuation | — | — |
| Total raised | — | $103M (disclosed rounds) |
| Last round | — | Series C, $42 million, Sep 2024 |
| Profile | Healthians on StopDown | Redcliffe Labs on StopDown |
Scale
Redcliffe was the larger of the two in FY25. It reported operating revenue of ₹419 crore, up from ₹348 crore in FY24. Healthians reported operating revenue of ₹263 crore for FY25 and ₹357 crore for FY26.
Healthians grew quickly in the latest year of its profile, rising from ₹263 crore to ₹357 crore. Redcliffe's FY26 figure is not in its profile, so the two cannot yet be compared on FY26.
Money
Healthians reported its first net profit for FY26, of ₹5.4 crore. In FY25 it had a net loss of ₹4.77 crore.
Redcliffe's FY24 loss was ₹250 crore as reported by Entrackr. For FY25 the profile gives no net result, only an EBITDA margin of about -21%. On the available data Healthians is the nearer to break even.
Where they are heading
Redcliffe has been buying. In Sep 2024 it acquired Celara Diagnostics for up to ₹60 crore, and in Aug 2026 it acquired Megavision Diagnostics for about ₹40 crore. It also launched the Femcliffe women health platform in May 2025.
Healthians named Nishant Singhal as CEO in Jul 2025, and in Jan 2026 its executive chairman Deepak Sahni committed ₹100 crore to early-stage startups. Neither profile lists an IPO filing.
The numbers behind the table
Healthians: revenue and profit by year
| Year | Revenue | Profit or loss | Note |
|---|---|---|---|
| FY26 | ₹357 crore | ₹5.4 crore | operating revenue; total revenue ₹362 crore; net profit |
| FY25 | ₹263 crore | ₹4.77 crore loss | operating revenue; net loss; total expenses |
Redcliffe Labs: revenue and profit by year
| Year | Revenue | Profit or loss | Note |
|---|---|---|---|
| FY25 | ₹419 crore | — | operating revenue; EBITDA margin about -21% |
| FY24 | ₹348 crore | ₹250 crore loss | revenue from operations; loss as reported by Entrackr |
Redcliffe Labs: funding rounds
| Date | Round | Amount | Investors |
|---|---|---|---|
| Sep 2024 | Series C | $42 million | IFU (lead), LeapFrog Investments, HealthQuad, Spark Growth Ventures |
| 2022 | Series B | $61 million |
Questions people ask
Which is bigger, Healthians or Redcliffe Labs?
On FY25, Redcliffe Labs is bigger, with operating revenue of ₹419 crore against ₹263 crore for Healthians. Healthians reached ₹357 crore in FY26.
Is Healthians profitable?
Yes, for FY26. Healthians reported a net profit of ₹5.4 crore, its first, after a net loss of ₹4.77 crore in FY25.
Is Redcliffe Labs profitable?
No result is given for FY25 beyond an EBITDA margin of about -21%. It lost ₹250 crore in FY24, as reported by Entrackr.
Which raised more, Healthians or Redcliffe Labs?
Redcliffe Labs. Its profile shows $115 million raised in total, including a $61 million Series B in 2022 and a $42 million Series C in Sep 2024 led by IFU. Healthians lists no round.
Every figure on this page comes from the companies' StopDown profiles, which list the filing or statement behind each number: Healthians, Redcliffe Labs. Revenue is revenue from operations unless the note says otherwise; valuations are as disclosed at a round or by the company; nothing here is investment advice. How StopDown counts.